Valuation: MELA Sciences Inc

Market Cap 29.44T 25.37T 24.02T 21.77T 40.84T 28.13L 41.05T 3L 1L 14.31L 1L 1L 45.22L P/E 2024
-1.1x
P/E 2025 -0.94x
Enterprise Value 83.85L 72.25L 68.41L 62.01L 1.16Cr 80Cr 1.17Cr 8.12Cr 3.12Cr 41Cr 3.15Cr 3.08Cr 128.79Cr EV / Sales 2024
0.64x
EV / Sales 2025 0.51x
Free-Float
65.54%
Yield 2024 *
-
Yield 2025 -
Manager TitleAgeSince
Chief Executive Officer - 12/07/2026
Chief Operating Officer - 14/11/2023
Comptroller/Controller/Auditor 51 13/11/2024
Director TitleAgeSince
Chairman 58 03/07/2023
Director/Board Member 87 29/05/2018
Director/Board Member 61 27/03/2024
Change 5-day change 1-year change 3-year change Capi.($)
-0.27%+0.73%+28.03%+17.80% 23TCr
-0.47%-2.87%+5.73%-21.35% 14TCr
+0.96%+7.47%-13.29%+23.90% 13TCr
+2.62%-1.75%-55.75%-16.49% 6.23TCr
+1.82%+0.98%-18.43%-13.91% 4.94TCr
+1.72%-0.67%+13.27%+16.37% 4.86TCr
-1.23%-0.68%+16.09%+26.96% 4.14TCr
-0.60%+1.08%+36.19%+49.73% 4.01TCr
+2.23%+1.14%-17.56%+51.43% 3.12TCr
Average +0.80%-3.23%-0.63%+14.94% 8.55TCr
Weighted average by Cap. +0.49%-2.40%+4.19%+10.30%

Financials

2024 2025
Net sales 3.36Cr 2.89Cr 2.74Cr 2.48Cr 4.66Cr 320.64Cr 4.68Cr 33Cr 13Cr 163.13Cr 13Cr 12Cr 515.46Cr 3.07Cr 2.64Cr 2.5Cr 2.27Cr 4.26Cr 293.26Cr 4.28Cr 30Cr 11Cr 149.2Cr 12Cr 11Cr 471.44Cr
Net income -1.01Cr -86.9L -82.28L -74.58L -1.4Cr -96Cr -1.41Cr -9.77Cr -3.76Cr -49Cr -3.79Cr -3.7Cr -154.9Cr -62.61L -53.94L -51.08L -46.3L -86.86L -60Cr -87.3L -6.07Cr -2.33Cr -30Cr -2.35Cr -2.3Cr -96Cr
Net Debt 91.78L 79.08L 74.88L 67.87L 1.27Cr 88Cr 1.28Cr 8.89Cr 3.42Cr 45Cr 3.45Cr 3.37Cr 140.96Cr 83.56L 72L 68.17L 61.79L 1.16Cr 80Cr 1.17Cr 8.1Cr 3.11Cr 41Cr 3.14Cr 3.07Cr 128.33Cr
Logo MELA Sciences Inc
STRATA Skin Sciences, Inc. is a medical technology company in dermatology. The Company is engaged in developing, commercializing and marketing products for the treatment of dermatologic conditions. The Company operates through two segments: Dermatology Recurring Procedures and Dermatology Procedures Equipment. The Company’s products include the XTRAC and Pharos excimer lasers and VTRAC lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions. Its products also include the TheraClear Acne Therapy System utilized in the treatment of mild to moderate inflammatory, comedonal and pustular acne. The XTRAC and Pharos excimer laser technology emits highly concentrated ultraviolet (UV) light targeted primarily towards autoimmune dermatological skin disorders, such as psoriasis, vitiligo, atopic dermatitis, and eczema, among others. VTRAC is a UV light lamp system that works in much the same way as the XTRAC.
Employees
-
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!